AcquisitionOther

Grünenthal acquired cancer treatment Stivarga®

Public deal record from Trade press. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.

Deal tape row

Grünenthal -> cancer treatment Stivarga®

Open source record (Press) ↗
Bracton Partners

Sell-side M&A advisory for software, fintech and data companies. Everything on these pages is built from primary sources: SEC filings, company announcements, and the public record. No estimates and no unnamed sources.

M&A advisory only. No capital-raising services are offered. Nothing on this page is a valuation, a recommendation, or an offer of any security.